The Board shall review the Agency’s program for national laboratory certification for Federal workplace drug testing programs as required by Public Law 100-71 and as described in the Mandatory Guidelines for Federal Workplace Drug Testing Programs. It shall recommend areas for emphasis or de-emphasis, new or changed directions, and mechanisms or approaches for implementing recommendations. Periodically, the Board shall review specific science areas on new drugs of abuse and the methods necessary to detect their presence.
- 42 U.S.C. § 290aa(h), Section 501 of the Public Health Service Act (PDF | 44 KB)
- 42 U.S.C. § 217a, Section 222 of the Public Health Service Act, as amended (PDF | 70 KB)